A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.
All Cancer News
ALASSCA trial in PIK3CA-mutated Colorectal Cancer
ALASSCA Trial Results – 2025 ASCO Gastrointestinal Cancer Symposium. The ALASCCA trial, recently presented at ASC0 2025, evaluated aspirin after colorectal cancer resection in patients whose tumou ...
Aspirin: Scientist crack how painkiller might stop cancers from spreading - BBC News
Link to the BBC News article Scientific journal reports that ‘Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity’ Findings in the paper published in Nature on 5 ...
Study reports that 'Aspirin cuts risk of cancer death by 20%'
This headline, recently seen in the news, reports on a new journal publication which looked at a large number of previous studies. The researchers bought together data from studies of people with canc ...
News and Resources